DRW Securities LLC Purchases 27,789 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

DRW Securities LLC lifted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 186.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,719 shares of the exchange traded fund’s stock after buying an additional 27,789 shares during the quarter. DRW Securities LLC owned about 0.06% of SPDR S&P Biotech ETF worth $4,221,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of XBI. Fifth Third Bancorp lifted its stake in shares of SPDR S&P Biotech ETF by 3.4% in the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after purchasing an additional 3,922 shares during the period. PFG Investments LLC lifted its position in shares of SPDR S&P Biotech ETF by 9.2% during the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock valued at $2,303,000 after acquiring an additional 2,097 shares during the period. IFG Advisory LLC bought a new position in SPDR S&P Biotech ETF during the second quarter worth $241,000. Beaton Management Co. Inc. bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $212,000. Finally, Atria Wealth Solutions Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 56.1% during the second quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock valued at $1,539,000 after purchasing an additional 5,962 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $96.24 on Monday. SPDR S&P Biotech ETF has a one year low of $71.99 and a one year high of $105.47. The company has a market cap of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average of $98.44 and a 200-day moving average of $96.32.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.